Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Cell Biol
2004 Dec 06;1675:915-24. doi: 10.1083/jcb.200409011.
Show Gene links
Show Anatomy links
Nontranscriptional modulation of intracellular Ca2+ signaling by ligand stimulated thyroid hormone receptor.
Saelim N
,
John LM
,
Wu J
,
Park JS
,
Bai Y
,
Camacho P
,
Lechleiter JD
.
???displayArticle.abstract???
Thyroid hormone 3,5,3'-tri-iodothyronine (T3) binds and activates thyroid hormone receptors (TRs). Here, we present evidence for a nontranscriptional regulation of Ca2+ signaling by T3-bound TRs. Treatment of Xenopus thyroid hormone receptor beta subtype A1 (xTRbetaA1) expressing oocytes with T3 for 10 min increased inositol 1,4,5-trisphosphate (IP3)-mediated Ca2+ wave periodicity. Coexpression of TRbetaA1 with retinoid X receptor did not enhance regulation. Deletion of the DNA binding domain and the nuclear localization signal of the TRbetaA1 eliminated transcriptional activity but did not affect the ability to regulate Ca2+ signaling. T3-bound TRbetaA1 regulation of Ca2+ signaling could be inhibited by ruthenium red treatment, suggesting that mitochondrial Ca2+ uptake was required for the mechanism of action. Both xTRbetaA1 and the homologous shortened form of rat TRalpha1 (rTRalphaDeltaF1) localized to the mitochondria and increased O2 consumption, whereas the full-length rat TRalpha1 did neither. Furthermore, only T3-bound xTRbetaA1 and rTRalphaDeltaF1 affected Ca2+ wave activity. We conclude that T3-bound mitochondrial targeted TRs acutely modulate IP3-mediated Ca2+ signaling by increasing mitochondrial metabolism independently of transcriptional activity.
Figure 1. T3-bound TRβA1 increases IP3-induced Ca2+ wave period. (a) Spatial-temporal stacks of IP3 (â¼300 nM)-induced Ca2+ wave activity in a representative control (water injected) oocyte, a T3-treated (100 nM) oocyte expressing TRβA1 and a T3 (100 nM) treated oocyte. Each image is 745 à 745 μm. (b) Western blot showing expression of TRβA1. Protein extracts from all groups were collected and loaded at 0.5 oocytes per lane onto 10% SDS-PAGE. The membrane was probed with a monoclonal mouse antiâhuman TRs antibody (MA1-215) and labeled with an HRP-conjugated secondary antibody. (c) Histogram of average interwave period for each group of oocytes. n values in parentheses represent the total number of oocytes pooled from at least two frogs. Error bars correspond to the mean ± SEM. The asterisks (**) denote a statistic significant difference (ANOVA single factor, P < 0.0001).
Figure 2. Transcriptional activity of TRβA1 requires xRXRα and both cognate ligands. Transcriptional activity was monitored with the TRE-reporter vector, pSEAP (TRE). (a) Lanes 1 and 2 are negative (pSEAP(âve)) and positive (pSEAP(+ve)) vector controls. Oocytes expressing TRβA1 or TRβA1 plus xRXRα were incubated with 100 nM T3 (lanes 3â5) plus 100 nM RA (lane 5) for 3 d. Cytosolic extracts from each group of oocytes was prepared and loaded onto a 10% SDS-PAGE at 2.5 oocytes equivalents per lane. SEAP was detected with the polyclonal rabbit antiâhuman SEAP antibody and an HRP-conjugated secondary antibody. The SP labeled arrow indicates SEAP immunoreactivity, which was present only in oocytes expressing TRβA1 and xRXRα exposed to both T3 and RA. (b) Transcriptional activity of TRβA1 requires the pBOX within the DBD and the NLS. Oocytes expressing xTRβA1ÎpBox-NLS and xRXRα show no SEAP immunoreactivity when incubated with T3 (lane 6) or T3 plus RA (lane 7). Western blot analysis shows that xRXRα, TRβA1, and xTRβA1ÎpBox-NLS are expressed at comparable levels (Western blots below lanes 4â7). TRβA1 and xTRβA1ÎpBox-NLS were detected with the monoclonal mouse antiâhuman TRs antibody (MA1-215). xRXRα was detected with a polyclonal rabbit antiâhuman RXR antibody (Sc-774).
Figure 3. Acute modulation of Ca2+ signaling does not require heterodimerization of TRβA1 with xRXRα. (a) Spatial-temporal stacks of IP3-induced Ca2+ wave activity in control oocytes compared with oocytes expressing TRβA1 or TRβA1 with xRXRα. T3 (100 nM) and RA (100 nM) were added as indicated 10â15 min before injection with IP3 (â¼300 nM). Scale is the same as Fig. 1. (b) Western blots of oocytes expressing TRβA1 and xRXRα. Primary and secondary antibodies were identical to those used in Figs. 1 and 2. (c). Histogram of average interwave period (second) of each group of oocytes. The asterisks (**) denote a statistic significance using ANOVA single factor (P < 0.0001). Values in parentheses represent the number of oocytes.
Figure 4. The pBOX and NLSs of TRβA1 are not required for the acute regulation of Ca2+ signaling. (a) Schematic figure depicting the position of the pBOX deletion in the DBD and the NLS modification within TRβA1. (b) Spatial-temporal stack of IP3-induced Ca2+ wave activity in control oocytes compared with oocytes expressing TR mutants ÎpBox-NLS and ÎNLS. Oocytes expressing the TR mutants were incubated with T3 (100 nM) 10â15 min before IP3 (â¼300 nM) injections. (c) Western blot analysis confirming comparable levels of protein expression for both wild-type and mutant TRβA1. (d) Histogram of the average Ca2+ wave periods for each group of oocytes (n values are in parentheses). Statistic significance over control oocytes is indicated by the asterisks (**; ANOVA single factor, P < 0.0001).
Figure 5. T3 stimulation of oocytes expressing TRβA1 increases the ÎΨ. (a) Images of mitochondria labeled with the potential sensitive dye TMRE. The oocytes are expressing TRβA1 and have been exposed to T3 for the indicated amount of time. Images are 50 à 100 μm. (b) Histogram of the log of mitochondrial TMRE fluorescence (Fmito) divided by the cytosolic fluorescence (Fcyto) at the indicated times of T3 exposure. Values in parentheses refers to the number of mitochondrion analyzed. Statistical significance is indicated by the asterisks (**; ANOVA single factor, P < 0.001).
Figure 6. Ru360 blocks T3-bound TRβA1 increases in IP3-induced Ca2+ wave period. (a) Spatial-temporal stacks of the effect of Ru360 treatment on Ca2+ wave activity in control oocytes compared with oocytes expressing TRβA1as labeled. (b) Histogram of average interwave period (seconds) of each group of oocytes shown in a. The asterisk (*) denotes a statistic significance using ANOVA single factor (P < 0.01). Values in parentheses represent the number of oocytes.
Figure 7. T3 stimulation of oocytes expressing TRβA1 increases O2 consumption. (a) Plots of O2 levels in oocytes as labeled (n = 200 oocytes per group). (b) Histogram represents average change of O2 consumption rates (before and after T3 exposure) in control and xTRβA1 groups. Statistical significance is indicated by the asterisk (*; t test, P < 0.05).
Figure 8. Xenopus TRβA1 and NH2-terminal truncated rat TRα1 (rTRα1ÎF) localize to mitochondria. (a) Schematic diagram of TRs showing that rTRα1ÎF and xTRβA1 have a similar NH2 terminus. (b and c) Western blots of TRα1, rTRα1ÎF, and xTRβA1 expression in whole oocytes and mitochondrial extracts respectively. FL, full-length receptor; SH, shortened form of the receptor. Extracts were prepared from 300 oocytes in each group. All oocytes were exposed to 100 nM T3 for at least 15 min before organelle extraction. TRs were immunoprecipitated with a monoclonal mouse antiâhuman TRs antibody (MA1-215), captured with immobilized protein G, concentrated, and loaded onto a 10% SDS-PAGE. An HRP-conjugated secondary antibody was used for visualization.
Figure 9. NH2-terminal truncated rat TRα1 (rTRα1ÎF) stimulates O2 consumption. (a) Plots of O2 levels for oocytes expressing full-length rTRα1 with and without T3 compared with oocytes expressing the NH2-terminal truncated rTRα1ÎF with or without T3. Protocols used were identical to those described in Fig. 7. (b) Histogram of the average change of the O2 consumption rates after T3 exposure in rTRα1 versus rTRα1ÎF groups. The asterisk (*) indicates statistical significance (t test, P < 0.05).
Figure 10. The truncated rTRα1ÎF regulates intracellular Ca2+ release. (a) Spatio-temporal stacks of IP3-induced Ca2+ wave activity in control oocytes compared with oocytes expressing rTRα1ÎF or rTRα1ÎF. TR expressing oocytes were treated with 100 nM T3 10â15 min before IP3 (â¼300 nM) injections and confocal imaging. (b) Western blots of rTRα1 and rTRα1ÎF expression levels in experimental oocytes. (c) Histogram of the average interwave periods for each group (n values in parentheses). Note that rTRα1ÎF has significantly longer periods even though its expression levels are lower than those of full-length rTRα1. The asterisks (**) indicate statistical significance with P < 0.01 using ANOVA single factor.
Abbaticchio,
Hormones in the seminal fluid. The transport proteins of the thyroid hormones.
1981, Pubmed
Abbaticchio,
Hormones in the seminal fluid. The transport proteins of the thyroid hormones.
1981,
Pubmed
Ardail,
Evidence for the presence of alpha and beta-related T3 receptors in rat liver mitochondria.
1993,
Pubmed
Banker,
The thyroid hormone receptor gene (c-erbA alpha) is expressed in advance of thyroid gland maturation during the early embryonic development of Xenopus laevis.
1991,
Pubmed
,
Xenbase
Bhat,
Phosphorylation enhances the target gene sequence-dependent dimerization of thyroid hormone receptor with retinoid X receptor.
1994,
Pubmed
Borski,
Signal transduction mechanisms mediating rapid, nongenomic effects of cortisol on prolactin release.
2002,
Pubmed
Borski,
Nongenomic membrane actions of glucocorticoids in vertebrates.
2000,
Pubmed
Camacho,
Calreticulin inhibits repetitive intracellular Ca2+ waves.
1995,
Pubmed
,
Xenbase
Casas,
A variant form of the nuclear triiodothyronine receptor c-ErbAalpha1 plays a direct role in regulation of mitochondrial RNA synthesis.
1999,
Pubmed
Crespo-Armas,
The rapid alteration by tri-iodo-L-thyronine in vivo of both the ADP/O ratio and the apparent H+/O ratio in hypothyroid-rat liver mitochondria.
1987,
Pubmed
Das,
Control of mitochondrial ATP synthase in rat cardiomyocytes: effects of thyroid hormone.
1991,
Pubmed
Davis,
Nongenomic actions of thyroid hormone.
1996,
Pubmed
Davis,
Nongenomic actions of thyroid hormone on the heart.
2002,
Pubmed
Eliceiri,
Quantitation of endogenous thyroid hormone receptors alpha and beta during embryogenesis and metamorphosis in Xenopus laevis.
1994,
Pubmed
,
Xenbase
Farkas,
Simultaneous imaging of cell and mitochondrial membrane potentials.
1989,
Pubmed
Gunter,
The Ca2+ transport mechanisms of mitochondria and Ca2+ uptake from physiological-type Ca2+ transients.
1998,
Pubmed
Gunter,
Mechanisms by which mitochondria transport calcium.
1990,
Pubmed
Gunter,
Transport of calcium by mitochondria.
1994,
Pubmed
Gunter,
Mitochondrial calcium transport: physiological and pathological relevance.
1994,
Pubmed
Guo,
Estradiol-induced nongenomic calcium signaling regulates genotropic signaling in macrophages.
2002,
Pubmed
Guo,
Nongenomic testosterone calcium signaling. Genotropic actions in androgen receptor-free macrophages.
2002,
Pubmed
Hadzic,
A novel multifunctional motif in the amino-terminal A/B domain of T3Ralpha modulates DNA binding and receptor dimerization.
1998,
Pubmed
Hajnóczky,
Mitochondria suppress local feedback activation of inositol 1,4, 5-trisphosphate receptors by Ca2+.
1999,
Pubmed
Hajnóczky,
Decoding of cytosolic calcium oscillations in the mitochondria.
1995,
Pubmed
Hummerich,
Rapid stimulation of calcium uptake into rat liver by L-tri-iodothyronine.
1989,
Pubmed
Ichikawa,
Thyroid hormone action in the cell.
1995,
Pubmed
Iglesias,
Identification of the mitochondrial NADH dehydrogenase subunit 3 (ND3) as a thyroid hormone regulated gene by whole genome PCR analysis.
1995,
Pubmed
Jouaville,
Synchronization of calcium waves by mitochondrial substrates in Xenopus laevis oocytes.
1995,
Pubmed
,
Xenbase
Kawahara,
Developmental and regional expression of thyroid hormone receptor genes during Xenopus metamorphosis.
1991,
Pubmed
,
Xenbase
Lazar,
Thyroid hormone receptors: multiple forms, multiple possibilities.
1993,
Pubmed
Leid,
Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently.
1992,
Pubmed
Lieberherr,
Androgens increase intracellular calcium concentration and inositol 1,4,5-trisphosphate and diacylglycerol formation via a pertussis toxin-sensitive G-protein.
1994,
Pubmed
Lin,
Mitochondrial targeted cyclophilin D protects cells from cell death by peptidyl prolyl isomerization.
2002,
Pubmed
McCormack,
The role of Ca2+ ions in the regulation of intramitochondrial metabolism and energy production in rat heart.
1989,
Pubmed
Meehan,
Influence of thyroid hormone on the tissue-specific expression of cytochrome c oxidase isoforms during cardiac development.
1997,
Pubmed
Minshall,
Nongenomic vasodilator action of progesterone on primate coronary arteries.
2002,
Pubmed
Morel,
Kinetics of internalization and subcellular binding sites for T3 in mouse liver.
1996,
Pubmed
Moura,
Direct action of aldosterone on transmembrane 22Na efflux from arterial smooth muscle. Rapid and delayed effects.
1984,
Pubmed
Nagai,
Regulation of myocardial Ca2+-ATPase and phospholamban mRNA expression in response to pressure overload and thyroid hormone.
1989,
Pubmed
Oppenheimer,
Advances in our understanding of thyroid hormone action at the cellular level.
1987,
Pubmed
Oppenheimer,
Thyroid hormone action 1994: the plot thickens.
1994,
Pubmed
Pietras,
Endometrial cell calcium and oestrogen action.
1975,
Pubmed
Rizzuto,
Close contacts with the endoplasmic reticulum as determinants of mitochondrial Ca2+ responses.
1998,
Pubmed
Rizzuto,
Mitochondria as biosensors of calcium microdomains.
1999,
Pubmed
Rojas,
Thyroid hormones regulate the frequency of miniature end-plate currents in pre- and prometamorphic stages of the tadpole tail.
2003,
Pubmed
Romani,
Mobilization of Mg2+ from rat heart and liver mitochondria following the interaction of thyroid hormone with the adenine nucleotide translocase.
1996,
Pubmed
Scanlan,
3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone.
2004,
Pubmed
Schönfeld,
Thyroid hormone-induced expression of the ADP/ATP carrier and its effect on fatty acid-induced uncoupling of oxidative phosphorylation.
1997,
Pubmed
Sergeev,
1,25-Dihydroxyvitamin D3 evokes oscillations of intracellular calcium in a pancreatic beta-cell line.
1995,
Pubmed
Simpson,
Mitochondria support inositol 1,4,5-trisphosphate-mediated Ca2+ waves in cultured oligodendrocytes.
1996,
Pubmed
Soboll,
Thyroid hormone action on mitochondrial energy transfer.
1993,
Pubmed
Soboll,
Long-term and short-term changes in mitochondrial parameters by thyroid hormones.
1993,
Pubmed
Sterling,
Thyroid hormone action: identification of the mitochondrial thyroid hormone receptor as adenine nucleotide translocase.
1991,
Pubmed
Sterling,
Direct thyroid hormone activation of mitochondria: the role of adenine nucleotide translocase.
1986,
Pubmed
Sterling,
Mitochondrial binding of triiodothyronine (T3). Demonstration by electron-microscopic radioautography of dispersed liver cells.
1984,
Pubmed
Sterling,
Rapid effect of triiodothyronine on the mitochondrial pathway in rat liver in vivo.
1980,
Pubmed
Sterling,
Thyroid hormone action: effect of triiodothyronine on mitochondrial adenine nucleotide translocase in vivo and in vitro.
1995,
Pubmed
Szalai,
Calcium signal transmission between ryanodine receptors and mitochondria.
2000,
Pubmed
Wasserman,
Progesterone induces a rapid increase in [Ca2+]in of Xenopus laevis oocytes.
1980,
Pubmed
,
Xenbase
Wong,
Coordinated regulation of and transcriptional activation by Xenopus thyroid hormone and retinoid X receptors.
1995,
Pubmed
,
Xenbase
Wrutniak,
A 43-kDa protein related to c-Erb A alpha 1 is located in the mitochondrial matrix of rat liver.
1995,
Pubmed
Wrutniak-Cabello,
Thyroid hormone action in mitochondria.
2001,
Pubmed
Yaoita,
A correlation of thyroid hormone receptor gene expression with amphibian metamorphosis.
1990,
Pubmed
,
Xenbase
Ying,
Inhibition of mitochondrial calcium ion transport by an oxo-bridged dinuclear ruthenium ammine complex.
1991,
Pubmed
Zhou,
Nongenomic regulation of ENaC by aldosterone.
2001,
Pubmed